We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ananda Pharma Plc | AQSE:ANA | Aquis Stock Exchange | Ordinary Share | GB00BDQPXQ60 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.005 | 0.96% | 0.525 | 0.42 | 52.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 26.21 | 0.485 | 0.52 | 433,639 | 16:29:56 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Change of Name |
| 11/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Subscription to raise £150,000 |
| 09/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Further Promising Results for MRX1 |
| 03/12/2024 | 07:00 | UK RNS | Ananda Developments PLC Key Stability Testing Milestones Achieved for MRX1 |
| 12/11/2024 | 07:00 | UK RNS | Ananda Developments PLC Director Dealing |
| 31/10/2024 | 07:00 | UK RNS | Ananda Developments PLC Total Voting Rights |
| 30/10/2024 | 12:15 | ALNC |  IN BRIEF: Ananda Developments loss widens as interest bill triples |
| 30/10/2024 | 07:00 | UK RNS | Ananda Developments PLC Interims for the six months ended 31 July 2024 |
| 21/10/2024 | 06:00 | UK RNS | Ananda Developments PLC Ananda Developments Epilepsy Trials |
| 09/10/2024 | 11:52 | ALNC | Ananda Developments inks contract to investigate lead MRX1 asset |
1 Year Ananda Pharma Chart |
Intraday Ananda Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
